MYB mRNA and protein levels did show a moderate correlation in both HL and DLBCL, with exception of the two HL cell lines with a truncating mutation in MYB, resulting in loss of the binding site of the MYB antibody. This evidence concerns the gene MYB and Hodgkins lymphoma.